A Phase 2b Randomized, Double Blind, Placebo-Controlled, Multicenter Study Evaluating Safety and Efficacy of EDP-305 in Subjects with Liver Biopsy Proven Non-Alcoholic Steatohepatitis (NASH)"

Administered By

Awarded By

Contributors

Start/End

  • March 10, 2020 - March 9, 2022